Recently, journalists have targeted Portland, OR as the exemplar for an emergent debate: as the addiction crisis rages on, are policies that decriminalize low-level drug crimes helping or hurting?

The disparities faced by the LGBTQ+ community in addiction treatment demand our attention. Understanding the specific challenges and consequences is crucial for promoting inclusivity and improving outcomes. It is our collective responsibility in the medical field to address these disparities through increased support, research, and advocacy.

I’ve been a nurse in Ohio for three decades and, for the past ten years, I’ve been focused on Opioid Use Disorder patients. I have never seen a more effective model than the collaborative, whole-patient approach at Boulder Care.

The COVID-era PHE made SUD care accessible in a profound new way. But that could all change once the PHE expires. Boulder has been preparing to ensure continuity of care for our current and future patients and is actively advocating for better regulations to help all people in need of addiction care.

Mia Michalak, one of Boulder's clinicians, explains why a new, stronger version of the overdose medication, Narcan, may not be helpful to those who need it most.

Stephanie Strong, Boulder’s CEO, explains how powerful it was to hear President Biden acknowledge harm reduction and medicines to treat Opioid Use Disorder in his State of The Union speech, and what this change of heart could mean for the public health crisis going forward.

Ben MacLean, Boulder's General Counsel, explains how laws and regulations can fight against patients with SUDs and stand in the way of better treatment options.